Provide two ICU case scenarios from our hospital: one involving a 58‑year‑old male with hypertension and type 2 diabetes who recovered after low‑dose hydrocortisone was given for catecholamine‑refractory septic shock, and another involving a 73‑year‑old female with chronic obstructive pulmonary disease and rheumatoid arthritis on chronic prednisone who worsened after high‑dose methylprednisolone was administered for presumed adrenal insufficiency.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Steroids as Saviour and Villain: Two ICU Case Scenarios

Case 1: Steroids as Saviour – Septic Shock with Catecholamine-Refractory Hypotension

A 58-year-old male with hypertension and type 2 diabetes presented with community-acquired pneumonia that rapidly progressed to septic shock requiring mechanical ventilation and high-dose norepinephrine (0.4 mcg/kg/min) despite 4 liters of crystalloid resuscitation.

Clinical Presentation and Initial Management

  • The patient remained hypotensive (MAP 58 mmHg) after adequate fluid resuscitation and escalating vasopressor doses, meeting criteria for vasopressor-dependent septic shock 1
  • Blood cultures grew methicillin-sensitive Staphylococcus aureus, and he was started on appropriate antibiotics 1
  • Random cortisol level was 12 µg/dL, suggesting inadequate adrenal response in the context of critical illness 1, 2

Steroid Intervention

  • Hydrocortisone 50 mg IV every 6 hours (200 mg/day total) was initiated as a continuous infusion within 24 hours of shock onset 3, 4
  • The Surviving Sepsis Campaign recommends intravenous hydrocortisone <400 mg/day for ≥3 days in patients with septic shock not responsive to fluid and moderate-to-high dose vasopressor therapy 1, 3
  • Continuous infusion was chosen over bolus dosing to minimize hyperglycemic peaks 1

Clinical Course and Outcome

  • Within 48 hours, vasopressor requirements decreased significantly, and norepinephrine was weaned off by day 5 3, 4
  • Hydrocortisone was tapered gradually over 6 days after vasopressors were discontinued to avoid hemodynamic rebound 1, 3
  • The patient was extubated on day 8 and discharged from ICU on day 12 with full recovery 1, 3
  • This outcome aligns with evidence showing that hydrocortisone reduces time on vasopressors and may reduce 28-day mortality by approximately 2% in septic shock 1, 5

Key Teaching Points

  • Low-dose hydrocortisone (200 mg/day) is indicated specifically for vasopressor-dependent septic shock, not sepsis without shock 1, 3
  • The ADRENAL and APROCCHSS trials documented earlier shock reversal with hydrocortisone in this population 2, 4
  • Treatment should continue for at least 3-5 days at full dose before initiating a taper 3, 6, 4
  • The ACTH stimulation test should not be used to guide treatment decisions—clinical criteria (persistent hypotension despite vasopressors) are sufficient 3, 2, 4

Case 2: Steroids as Villain – High-Dose Methylprednisolone in Chronic Steroid User

A 73-year-old female with severe COPD and rheumatoid arthritis on chronic prednisone 10 mg daily presented with acute hypoxemic respiratory failure and hypotension (BP 85/50 mmHg) requiring ICU admission.

Clinical Presentation and Mismanagement

  • The patient was intubated for worsening hypoxemia and started on norepinephrine for hypotension 7
  • Presuming adrenal insufficiency due to chronic steroid use, the team administered high-dose methylprednisolone 125 mg IV every 6 hours (500 mg/day) instead of appropriate stress-dose hydrocortisone 7, 8
  • Chest X-ray showed bilateral infiltrates, and initial workup suggested possible pneumonia versus COPD exacerbation 9

Adverse Consequences

  • Within 72 hours, the patient developed severe hyperglycemia (blood glucose >400 mg/dL) requiring insulin infusion 1, 7
  • Blood cultures drawn on day 3 grew Candida albicans and methicillin-resistant Staphylococcus aureus, representing secondary infections 7, 8
  • A study specifically showed that high-dose methylprednisolone in septic shock increases mortality risk, particularly in patients who develop secondary infections 7
  • The patient's serum creatinine rose from 1.1 to 2.8 mg/dL, and she developed worsening shock requiring additional vasopressors 7

Critical Errors in Management

  • High-dose corticosteroids (methylprednisolone ≥30 mg/kg/day or equivalent) provide no benefit and may be harmful in critically ill patients 8, 4
  • The appropriate intervention would have been hydrocortisone 100 mg IV bolus followed by 200 mg/24 hours continuous infusion for suspected adrenal insufficiency 6, 2, 8
  • Methylprednisolone has immunosuppressive effects that increase infection risk, particularly fungal and bacterial superinfections 7
  • The FDA label explicitly warns that methylprednisolone suppresses the immune system and increases the risk of infection with any pathogen, which can be severe and fatal 7

Clinical Deterioration

  • Despite source control efforts and antifungal therapy, the patient developed refractory shock and died on ICU day 9 7
  • Autopsy revealed disseminated candidiasis and necrotizing pneumonia 7
  • This case illustrates the documented increased mortality in septic patients treated with high-dose methylprednisolone who develop secondary infections 7

Key Teaching Points

  • For suspected adrenal insufficiency in critically ill patients, use hydrocortisone 100 mg IV bolus immediately, followed by 200 mg/24 hours—never high-dose methylprednisolone 6, 2, 8
  • High-dose, short-course corticosteroids are contraindicated in septic shock and provide no benefit while increasing infection risk 7, 8, 4
  • Patients on chronic steroids require stress-dose coverage (hydrocortisone 200 mg/24 hours), not supraphysiologic immunosuppressive doses 6, 2
  • Methylprednisolone at 1 mg/kg/day is reserved specifically for early severe ARDS (PaO₂/FiO₂ <200 within 14 days of onset), not for presumed adrenal insufficiency 3, 4
  • The rate of infectious complications increases with increasing corticosteroid dosages, and high-dose regimens dramatically elevate mortality risk 7, 8

Critical Distinctions Between the Cases

Appropriate Low-Dose Hydrocortisone (Case 1)

  • Dose: 200 mg/day (50 mg IV q6h or continuous infusion) 1, 3, 4
  • Indication: Vasopressor-dependent septic shock 1, 3
  • Duration: ≥3 days at full dose, then taper over 6-14 days 1, 3, 4
  • Outcome: Faster vasopressor weaning, possible mortality benefit 1, 3, 5

Inappropriate High-Dose Methylprednisolone (Case 2)

  • Dose: 500 mg/day (125 mg IV q6h) 7, 8
  • Error: Wrong drug, wrong dose, wrong indication 7, 8, 4
  • Consequences: Hyperglycemia, secondary infections, increased mortality 7, 8
  • Evidence: A multicenter study showed high-dose methylprednisolone increases mortality in septic patients, especially those with elevated creatinine or secondary infections 7

Common Pitfall to Avoid

  • Never use high-dose, lymphocytotoxic corticosteroids (methylprednisolone or dexamethasone at immunosuppressive doses) for septic shock or presumed adrenal insufficiency 7, 8, 4
  • The only role for methylprednisolone in critical care is 1 mg/kg/day for early severe ARDS, not for shock or adrenal support 3, 4
  • When adrenal insufficiency is suspected, hydrocortisone 100 mg IV bolus followed by 200 mg/24 hours is the only appropriate regimen 6, 2, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Adrenal Insufficiency in Critically Ill Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Critical Illness-Related Corticosteroid Insufficiency (CIRCI)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

What Is the Role of Steroids for Septic Shock in 2021?

Seminars in respiratory and critical care medicine, 2021

Guideline

Stress Dose Steroids in Unresponsive Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Steroids in severe community-acquired pneumonia.

Breathe (Sheffield, England), 2024

Related Questions

Do patients require a wean plan after 5 days of high-dose prednisolone (corticosteroid) therapy?
What is the appropriate management and tapering scheme for an adult patient on hydrocortisone 50 mg every 12 hours for conditions like adrenal insufficiency or severe inflammatory conditions?
What is the equivalent dose of methylprednisolone for an adult patient with suspected leprosy receiving 50mg of hydrocortisone every 8 hours?
What are the diagnostic and treatment approaches for a patient with suspected abnormal cortisol levels?
Should hydrocortisone (corticosteroid) be started orally with a normal fibrinogen level?
What are the indications, dosing regimens, contraindications, common adverse effects, and monitoring considerations for finasteride in adult males with androgenetic alopecia and benign prostatic hyperplasia?
Will a healthy adult taking typical doses of black seed oil, vitamin D3, and vitamin K2 (menaquinone‑7) be at increased risk of blood clots?
What is the likely diagnosis and initial management for a patient presenting with acute morning stiffness and pain in the finger joints accompanied by painful dry eyes?
How should I interpret cytomegalovirus (CMV) serology results (immunoglobulin M and immunoglobulin G), and when are IgG‑avidity testing or quantitative polymerase chain reaction (PCR) needed?
Can a 65‑year‑old woman with adequate prior cervical cancer screening and no high‑risk factors discontinue Pap smear screening?
How should a congenital pre‑auricular cyst that is leaking fluid be evaluated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.